Items Tagged ‘Ovarian Cancer’

June 18, 2018

Newly Diagnosed with Ovarian Cancer? 10 Must Read Tips to be an Empowered Patient

By

For many years ovarian cancer has been referred to as “the silent killer” due to its vague, ignored, or misdiagnosed symp­toms. Because of this and the lack of ear­ly-detection tools, ovarian cancer often goes undiagnosed until it has reached the later stages, when it is harder to treat. Information and support and are key to […]

View full entry

Tags: News, Ovarian Cancer


May 16, 2018

PARP – Checkpoint Inhibitor Combo Promising in Ovarian Cancer

By

CancerConnect News: The combination of a PARP inhibitor and a checkpoint inhibitor appears promising as treatment for patients with ovarian cancer, according to results of a clinical study reported at the 2018 Society for Gynecologic Oncology Annual Meeting on Women’s Cancer in New Orleans, Louisiana.  Preliminary results from the study suggest that the combination could provide meaningful […]

View full entry

Tags: checkpoint inhibitor, News, Ovarian Cancer, PARP Inhibitors, PD-1, Precision Cancer Medicine


April 9, 2018

Rubraca® Approved as Maintenance Treatment of Recurrent Ovarian Cancer

By

CancerConnect News: Rubraca® (rucaparib) has been approved for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Biomarker testing is not required for patients to be prescribed Rubraca in this maintenance treatment indication. About Rubraca® Rubraca® is […]

View full entry

Tags: cancer treatment, News, ovarian, Ovarian Cancer, poly ADP-ribose polymerase (PARP) inhibitor, recurrent, Rubraca, treatment


March 15, 2018

It’s in the Genes: Genetic Testing for Ovarian Cancer 

By

What your DNA reveals and why it’s worth knowing CancerConnect News: Ovarian cancer is often dubbed as the “silent killer” of women. The symptoms are vague—including bloating, fatigue, irregular bleeding, frequent urination, and back pain1 —making it difficult to diagnose early. By way of comparison, detection and treatment of breast cancer has progressed tremendously. This […]

View full entry

Tags: News, Ovarian Cancer


January 22, 2018

Chemo Bath Improves Ovarian Cancer Survival

By

CancerConnect News: A heated chemotherapy bath circulated throughout the abdomen after surgery can significantly prolong a woman’s survival with advanced ovarian cancer, according to the results of a study published in the prestigious New England Journal of Medicine this week.1 About Ovarian Cancer Each year in the United States, roughly 22,000 women are diagnosed with […]

View full entry

Tags: News, Ovarian Cancer


January 18, 2018

Rubraca Significantly Improves Survival Ovarian Cancer

By

CancerConnect News: According to the results of a recently published clinical trail the novel precision cancer medicine Rubraca® (rucaparib) improves the outcomes of individuals with advanced ovarian cancer. About Rubraca® Rubraca® is an oral taken poly ADP-ribose polymerase (PARP) inhibitor that works by blocking PARP1, PARP2 and PARP3 enzyme involved in repairing damaged DNA. By […]

View full entry

Tags: News, Ovarian Cancer, Rubraca


January 16, 2018

Ovarian Cancer: Doctors at Sloan Kettering Explore Immunotherapy

By

CancerConnect News:  All gynecologic cancers are challenging to treat. They can be hard to find and are usually diagnosed when they are advanced. Although these cancers can be held at bay with surgery or chemotherapy, they often return and become difficult to control. Researchers at Memorial Sloan Kettering are exploring whether harnessing the power of […]

View full entry

Tags: News, Ovarian Cancer


September 11, 2017

Pass it On: It’s National Ovarian Cancer Awareness Month

By

In 2016, the American Cancer Association estimates that 22,280 women will be diagnosed with ovarian cancer, and 14,240 women will die from the disease. The incidence of ovarian cancer has decreased slightly in the past decade or so, though the reason for this decrease remains unknown. Ovarian cancer usually has no obvious symptoms but some […]

View full entry

Tags: awareness month, genetic testing, hereditary, News, Ovarian Cancer, prevention


May 26, 2015

Lynparza™

By

Class: Biological Therapy Generic Name: Olaparib Trade Name: Lynparza™ For which conditions is this drug approved? Lynparza is used treat women with advanced ovarian cancer who have: a) received previous treatment with three or more prior chemotherapy medicines or a combination of chemotherapy medicines; and b) have a certain type of abnormal inherited BRCA gene. […]

View full entry

Tags: Biological Therapy, Drug Dictionary, L, Ovarian Cancer, PARP inhibitor


May 26, 2015

Olaparib

By

Class: Biological Therapy Generic Name: Olaparib Trade Name: Lynparza™ For which conditions is this drug approved? Lynparza is used treat women with advanced ovarian cancer who have: a) received previous treatment with three or more prior chemotherapy medicines or a combination of chemotherapy medicines; and b) have a certain type of abnormal inherited BRCA gene. […]

View full entry

Tags: Biological Therapy, Drug Dictionary, lynparza, O, Ovarian Cancer, PARP inhibitor


February 8, 2009

For Optimal Care of Gynecologic Cancers, Consult Your Oncologist About Medication Concerns

By

As a patient or caregiver affected by a gynecologic cancer diagnosis, you can help your gynecologic oncologist ensure that you or your loved one receive the best possible care. Learn all about each prescribed medicine—both new drugs and routine drugs taken for some time. This is crucial, whether you are the patient or a caregiver […]

View full entry

Tags: Bladder Cancer, Cervical Cancer, Ovarian Cancer, Uterine Cancer


February 6, 2009

Genetic Testing For Women at High Risk of Ovarian Cancer

By

When risk is assessed appropriately and testing is managed effectively, genetic testing for BRCA1 and BRCA2 mutations can provide patients at risk of ovarian cancer with information, options, and ultimately empowerment. By Krishnansu S. Tewari, MD, FACOG, FACS Introduction Ovarian cancer is the number one gynecologic cancer killer in the United States. Approximately 22,000 women […]

View full entry

Tags: Ovarian Cancer


February 6, 2009

Understanding Hereditary Breast and Ovarian Cancer

By

Recent studies have explored the limitations of genetic testing for breast and ovarian cancer risk. As well, these studies have clarified cancer risk among women with and without known genetic mutations. Inherited mutations in two genes—BRCA1 and BRCA2—have been found to greatly increase the lifetime risk of developing breast and ovarian cancer. Alterations in these […]

View full entry

Tags: Breast Cancer, Ovarian Cancer


February 6, 2009

Four Points to Remember About Heredity and Ovarian Cancer

By

Hereditary predisposition to ovarian cancer accounts for small (5–10%) but significant group of patients. Recognition of this fact allows women and their physicians to assess the role of genetic counseling and testing to determine their risk. If a mutation is detected, the risk of developing ovarian cancer is marked and interventions are warranted—either for early […]

View full entry

Tags: Ovarian Cancer


February 6, 2009

Ask the Doctor: Questions and Answers About Ovarian Cancer

By

With Andrew W. Menzin, MD, FACOG, FACS Q. Is heredity an important factor in ovarian cancer? A. Only 5–10% of ovarian cancers are thought to occur due to a hereditary predisposition. Despite this fact, knowledge of family history is important information for both a patient and her physician because of the potential preventive and treatment […]

View full entry

Tags: Ovarian Cancer